← Back to Search

Device

Boppli Infant Blood Pressure Monitor for High Blood Pressure

N/A

Waitlist Available

Led By Kamran Yusuf, Ph.D.

Research Sponsored by PyrAmes Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 - 72 hours

Awards & highlights

Study Summary

This trial found that the Boppli device was able to provide accurate readings of systolic, diastolic, and mean arterial blood pressure for infants in an intensive care setting, comparable to those of an invasive arterial line.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 - 72 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 - 72 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 - 72 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Assess the accuracy and precision of the Boppli System in continuous blood pressure monitoring

Secondary outcome measures

Assess the safety of the Boppli System in a clinical setting

Trial Design

1Treatment groups

Experimental Treatment

Group I: ExperimentalExperimental Treatment1 Intervention

The Boppli device will be applied to the patients' arm or foot on either side of the body and is intended for single use of up to 72 hours and is discarded following use. The device will only be used in patients requiring continuous blood pressure monitoring, through the use of an invasive arterial line (IAL), to compare the data obtained by the Boppli to that obtained by the IAL.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Boppli Infant Blood Pressure Monitor

2022

N/A

~10

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

PyrAmes Inc.Lead Sponsor

University of CalgaryOTHER

791 Previous Clinical Trials

868,726 Total Patients Enrolled

Kamran Yusuf, Ph.D.Principal InvestigatorUniversity of Calgary - Department of Pediatrics

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the enrollment count for this trial?

"Affirmative. Perusal of clinicaltrials.gov reveals that this research initiative, which was introduced on June 22nd 2022, is still recruiting participants. 25 individuals are needed at one medical site for the study to be completed successfully."

Answered by AI

Does this research project currently have space for new participants?

"Affirmative. Clinicaltrials.gov displays that this medical survey, which was announced on June 22nd 2022 is actively recruiting patients. A total of 25 individuals need to be enrolled from a single site for the trial's completion."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Non-invasive Continuous Blood Pressure Monitoring

2022. "Non-invasive Continuous Blood Pressure Monitoring". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05224011.